C. Bash

1.5k total citations
21 papers, 1.2k citations indexed

About

C. Bash is a scholar working on Pathology and Forensic Medicine, Rheumatology and Oncology. According to data from OpenAlex, C. Bash has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 9 papers in Rheumatology and 4 papers in Oncology. Recurrent topics in C. Bash's work include Multiple Sclerosis Research Studies (19 papers), Systemic Lupus Erythematosus Research (8 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). C. Bash is often cited by papers focused on Multiple Sclerosis Research Studies (19 papers), Systemic Lupus Erythematosus Research (8 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). C. Bash collaborates with scholars based in United States, Italy and Germany. C. Bash's co-authors include Henry F. McFarland, Joseph A. Frank, Lael A. Stone, Heidi Maloni, Peter A. Calabresi, Joseph A. Frank, Nancy Richert, Paul S. Albert, Mary E. Smith and T. Howard and has published in prestigious journals such as Neurology, Annals of Neurology and Journal of Neuroimmunology.

In The Last Decade

C. Bash

21 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Bash United States 17 890 337 278 272 267 21 1.2k
C. Polman Netherlands 10 1.0k 1.1× 419 1.2× 374 1.3× 284 1.0× 192 0.7× 17 1.4k
Leonora Fisniku United Kingdom 9 1.2k 1.3× 398 1.2× 432 1.6× 123 0.5× 222 0.8× 14 1.3k
Uschi Brehm Germany 7 753 0.8× 264 0.8× 358 1.3× 523 1.9× 139 0.5× 7 1.1k
Lars Börnsen Denmark 18 752 0.8× 202 0.6× 265 1.0× 487 1.8× 250 0.9× 32 1.3k
M.A.A. van Walderveen Netherlands 7 1.2k 1.3× 327 1.0× 449 1.6× 98 0.4× 135 0.5× 9 1.4k
Lenka Novakova Sweden 17 1.1k 1.2× 250 0.7× 496 1.8× 323 1.2× 353 1.3× 45 1.5k
P. D. Molyneux United Kingdom 13 789 0.9× 300 0.9× 362 1.3× 62 0.2× 142 0.5× 16 980
Alejandro Horga Spain 20 728 0.8× 254 0.8× 456 1.6× 103 0.4× 155 0.6× 46 1.4k
Kryshani Fernando United Kingdom 14 967 1.1× 320 0.9× 434 1.6× 67 0.2× 167 0.6× 18 1.2k
Josephine Swanton United Kingdom 17 1.2k 1.4× 450 1.3× 611 2.2× 90 0.3× 218 0.8× 21 1.4k

Countries citing papers authored by C. Bash

Since Specialization
Citations

This map shows the geographic impact of C. Bash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bash more than expected).

Fields of papers citing papers by C. Bash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bash. The network helps show where C. Bash may publish in the future.

Co-authorship network of co-authors of C. Bash

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bash. A scholar is included among the top collaborators of C. Bash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bash. C. Bash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richert, Nancy, T. Howard, Joseph A. Frank, et al.. (2006). Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis. Neurology. 66(4). 551–556. 26 indexed citations
2.
Pulicken, Mathew, C. Bash, Kathleen Costello, et al.. (2005). Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis. Multiple Sclerosis Journal. 11(2). 169–174. 24 indexed citations
3.
Bielekova, Bibiana, Nadja Kadom, Elizabeth Fisher, et al.. (2005). MRI as a marker for disease heterogeneity in multiple sclerosis. Neurology. 65(7). 1071–1076. 55 indexed citations
4.
Frank, Joseph A., Nancy Richert, C. Bash, et al.. (2004). Interferon-β-1b slows progression of atrophy in RRMS. Neurology. 62(5). 719–725. 65 indexed citations
5.
Frank, J A, Nancy Richert, Bobbi K. Lewis, et al.. (2002). A pilot study of recombinant insulin-like growth factor-1 in seven multiple sclerosis patients. Multiple Sclerosis Journal. 8(1). 24–29. 74 indexed citations
6.
Richert, Nancy, Bobbi K. Lewis, C. Bash, et al.. (2002). A pilot study of recombinant insulin-like growth factor-I in seven multiple sclerosis patients. Multiple Sclerosis Journal. 8(1_suppl). 24–29. 2 indexed citations
7.
Rao, Archana, Nancy Richert, T. Howard, et al.. (2002). Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNβ-1b. Neurology. 59(5). 688–694. 58 indexed citations
8.
Richert, Nancy, et al.. (2000). MRI and clinical activity in MS patients after terminating treatment with interferon beta-l b. Multiple Sclerosis Journal. 6(2). 86–90. 24 indexed citations
9.
Bagnato, Francesca, Andrea Tancredi, Nancy Richert, et al.. (2000). Contrast-enhanced magnetic resonance activity in relapsing remitting multiple sclerosis patients: a short term natural history study. Multiple Sclerosis Journal. 6(1). 43–49. 7 indexed citations
10.
Zipp, Frauke, Michael Weller, Peter A. Calabresi, et al.. (1998). Increased serum levels of soluble CD95 (APO‐1/Fas) in relapsing‐remitting multiple sclerosis. Annals of Neurology. 43(1). 116–120. 59 indexed citations
11.
Calabresi, Peter A., Eileen C. Farnon, Joseph A. Frank, et al.. (1998). ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions. Journal of Neuroimmunology. 85(2). 212–219. 27 indexed citations
12.
Richert, Nancy, John Ostuni, C. Bash, et al.. (1998). Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b.. PubMed. 19(9). 1705–13. 54 indexed citations
13.
Calabresi, Peter A., Laura R. Tranquill, James M. Dambrosia, et al.. (1997). Increases in soluble VCAM‐1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β‐1b. Annals of Neurology. 41(5). 669–674. 129 indexed citations
14.
Schwartz, Paul J., C. Bash, Erick H. Turner, et al.. (1997). Seasonality and pituitary volume. Psychiatry Research Neuroimaging. 74(3). 151–157. 28 indexed citations
15.
Stone, Lael A., Joseph A. Frank, Paul S. Albert, et al.. (1997). Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure. Neurology. 49(3). 862–869. 96 indexed citations
16.
Calabresi, Peter A., Lael A. Stone, C. Bash, Joseph A. Frank, & Henry F. McFarland. (1997). Interferon beta results in immediate reduction of contrast‐enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI. Neurology. 48(5). 1446–1448. 65 indexed citations
17.
Frank, J A, C. Bash, Lael A. Stone, et al.. (1996). Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: Baseline versus betaseron treatment trials. Academic Radiology. 3. S173–S175. 2 indexed citations
18.
Bash, C., et al.. (1995). MRI of silicone vitreous ocular implants with phantom correlation. Neuroradiology. 37(4). 313–316. 6 indexed citations
19.
Stone, Lael A., Joseph A. Frank, Paul S. Albert, et al.. (1995). The effect of interferon‐β on blood—brain barrier disruptions demonstrated by constrast‐enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosis. Annals of Neurology. 37(5). 611–619. 206 indexed citations
20.
Stone, Lael A., Mary E. Smith, Paul S. Albert, et al.. (1995). Blood‐brain barrier disruption on contrast‐enhanced MRI in patients with mild relapsing‐remitting multiple sclerosis. Neurology. 45(6). 1122–1126. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Polman Breakdown of academic impact, for papers by Leonora Fisniku Breakdown of academic impact, for papers by Uschi Brehm Breakdown of academic impact, for papers by Lars Börnsen Breakdown of academic impact, for papers by M.A.A. van Walderveen Breakdown of academic impact, for papers by Lenka Novakova Breakdown of academic impact, for papers by P. D. Molyneux Breakdown of academic impact, for papers by Alejandro Horga Breakdown of academic impact, for papers by Kryshani Fernando Breakdown of academic impact, for papers by Josephine Swanton
Rankless by CCL
2026